Kazushige Satoh

Successful Use of Anti-CD20 Monoclonal Antibody (Rituximab) for ABO-Incompatible Living-Related Liver Transplantation

Masahiro Usuda, Keisei Fujimori, Nozomi Koyamada et al. · Transplantation · 2004 · 90 citations

Attenuation of Cross-Talk Between the Complement and Coagulation Cascades by C5a Blockade Improves Early Outcomes After Intraportal Islet Transplantation

Kazuaki Tokodai, Masafumi Goto, Akiko Inagaki et al. · Transplantation · 2010 · 52 citations

Long-term Outcome after Living Donor Liver Transplantation for Two Cases of Homozygous Familial Hypercholesterolemia from a Heterozygous Donor

Naoki Kawagishi, Kazushige Satoh, Yorihiro Akamatsu et al. · Journal of Atherosclerosis and Thrombosis · 2007 · 37 citations · Full text

Risk Factors and Impact of .BETA.-D Glucan on Invasive Fungal Infection for the Living Donor Liver Transplant Recipients

Naoki Kawagishi, Kazushige Satoh, Yoshitaka Enomoto et al. · The Tohoku Journal of Experimental Medicine · 2006 · 18 citations · Full text

Antifungal Agent, Transplantation, Hepatology +11

Usefulness of beta-d glucan in diagnosing Pneumocystis carinii pneumonia and monitoring its treatment in a living-donor liver-transplant recipient

Naoki Kawagishi, Shigehito Miyagi, Kazushige Satoh et al. · Journal of Hepato-Biliary-Pancreatic Surgery · 2007 · 16 citations

Living-donor Liver-transplant Recipient, Hepatology, Pathology +3